Where does Lumen Biomedical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lumen Biomedical, Inc. ranks #48,468 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lumen Biomedical, Inc. hold?

Lumen Biomedical, Inc. holds 5 US utility patents granted between 2015 and 2021, spanning 3 technology areas.

What is Lumen Biomedical, Inc.'s Innovation Score?

Lumen Biomedical, Inc. has an Innovation Score of 21.1 out of 100 (8th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Lumen Biomedical, Inc. focus on?

Lumen Biomedical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 5 patents. Grants appear in 3 CPC subclasses total.

Is Lumen Biomedical, Inc.'s patent grant rate increasing or decreasing?

Lumen Biomedical, Inc.'s recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Lumen Biomedical, Inc.'s patents?

Lumen Biomedical, Inc.'s patents average 14.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lumen Biomedical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Lumen Biomedical, Inc.

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lumen ranks #48,468 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#48,468
of 49,997 US assignees by volume: 8th percentile
by Innovation Score (21.1/100): 14.6
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R48468 · US Corporation #48,468 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,468/49,997
PHOTO-FINISH Lucid Vision Labs
CPC-NARROW A61B · 3 areas
INNOV-THIN 21.1/100
CLAIMS-RICH 14.6 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Lucid Vision Labs, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Lumen Biomedical · this assignee

21
3D Lighting… · lowest

7

What this shows Lumen's Innovation Score is 21.1/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Lumen's grants concentrate

Lumen Biomedical, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Lumen sits between Lucid Vision Labs, Inc. and LumiThera, Inc..

Lucid Vision Labs

5
Ludlum Measuremen…

5
Ludwig Ehrhardt

5
Lumacyte

5
Lumen Labs (HK)

5
Lumex Dmcc

5
Lumexis

5
Lumithera

5
Lumen Biomedical ◀

5

What this shows Lumen holds 5 patents at rank #48,488, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lumen

By rank, the assignees closest to #48,488 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Lumen's primary technology class.

Lumen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 8th percentile higher than 8% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Lumen Biomedical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	20.0%
2017	1	20.0%
2018	1	20.0%
2020	1	20.0%
2021	1	20.0%

Which technologies does Lumen Biomedical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 5

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#48,468

of 49,997 tracked assignees

Innovation Score

21.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Lumen Biomedical, Inc.'s patent record in context - here's where to go next.

Lumen Biomedical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #48,468 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lumen Biomedical, Inc. against Lucid Vision Labs, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 21.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.